‘Everyone is at fault’: With insulin prices skyrocketing, there’s plenty of blame to go around

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Feb 19, 2019 at 9:52 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,746
    Likes Received:
    3
    via Fifteen years ago, a patient with diabetes might have paid $175.57 for a 20-milliliter vial of the long-acting insulin Humulin R U-500.

    Today, he’d shell out $1,487 for the same tiny vial, according to wholesale acquisition cost data from Elsevier’s Gold Standard Drug Database.

    article source